Genetics & Genomics
Press coverage of genomics in Quebec are focus of review
Published in Medical Letter on the CDC and FDA, May 17th, 2006
According to the review, "Genomics integrates the promises and perils of modern biomedical science. Canada and the province of Quebec embarked late but aggressively in genomics research based on the 'discourse of promise' in which genomics is embedded. This did not prevent the emergence of a 'discourse of concerns', and debates on the wider meaning of genomics and on the risks related to genomics applications such as gene therapy and gene testing."
"Given this context this study aims to understand the evolution of genomics press coverage...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Allergy & Immunology
Competition ELISA is sensitive for detection of small allergen quantities - Epidemiology
Analysis of deaths with unknown cause in mortality analyses is discussed - Food-Borne Illness
Analyzing Campylobacter species on turkey farms benefits from multiple typing methods - Stroke
Preeclampsia increases risk of ischemic stroke among young women - Tuberculosis
Public-private collaborations can improve tuberculosis control in India - Adverse Drug Reaction
Adverse events after hepatitis A/B combination vaccine reported - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
